nodes	percent_of_prediction	percent_of_DWPC	metapath
Clemastine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.132	0.17	CbGbCtD
Clemastine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.132	0.17	CbGbCtD
Clemastine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.118	0.152	CbGbCtD
Clemastine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.111	0.143	CbGbCtD
Clemastine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0748	0.0966	CbGbCtD
Clemastine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0714	0.0921	CbGbCtD
Clemastine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0636	0.0821	CbGbCtD
Clemastine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0373	0.0482	CbGbCtD
Clemastine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0352	0.0455	CbGbCtD
Clemastine—Epigastric distress—Salbutamol—chronic obstructive pulmonary disease	0.00673	0.0316	CcSEcCtD
Clemastine—Extrasystoles—Aminophylline—chronic obstructive pulmonary disease	0.00431	0.0203	CcSEcCtD
Clemastine—Extrasystoles—Formoterol—chronic obstructive pulmonary disease	0.00328	0.0154	CcSEcCtD
Clemastine—Extrasystoles—Arformoterol—chronic obstructive pulmonary disease	0.00328	0.0154	CcSEcCtD
Clemastine—Extrasystoles—Salbutamol—chronic obstructive pulmonary disease	0.0031	0.0146	CcSEcCtD
Clemastine—Chest discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00295	0.0139	CcSEcCtD
Clemastine—Wheezing—Montelukast—chronic obstructive pulmonary disease	0.00263	0.0124	CcSEcCtD
Clemastine—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.00253	0.0119	CcSEcCtD
Clemastine—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00252	0.0118	CcSEcCtD
Clemastine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.00251	0.0118	CcSEcCtD
Clemastine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.00236	0.0111	CcSEcCtD
Clemastine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00234	0.011	CcSEcCtD
Clemastine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00231	0.0109	CcSEcCtD
Clemastine—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00224	0.0105	CcSEcCtD
Clemastine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00223	0.0105	CcSEcCtD
Clemastine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.0104	CcSEcCtD
Clemastine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.0022	0.0104	CcSEcCtD
Clemastine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00214	0.0101	CcSEcCtD
Clemastine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.0021	0.00989	CcSEcCtD
Clemastine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.00977	CcSEcCtD
Clemastine—Neuritis—Prednisolone—chronic obstructive pulmonary disease	0.002	0.00942	CcSEcCtD
Clemastine—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00188	0.00882	CcSEcCtD
Clemastine—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00181	0.0085	CcSEcCtD
Clemastine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00176	0.00826	CcSEcCtD
Clemastine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00171	0.00804	CcSEcCtD
Clemastine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00169	0.00794	CcSEcCtD
Clemastine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00167	0.00787	CcSEcCtD
Clemastine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00166	0.00781	CcSEcCtD
Clemastine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.0016	0.00753	CcSEcCtD
Clemastine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.0075	CcSEcCtD
Clemastine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00156	0.00732	CcSEcCtD
Clemastine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00154	0.00725	CcSEcCtD
Clemastine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00712	CcSEcCtD
Clemastine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00149	0.00699	CcSEcCtD
Clemastine—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00698	CcSEcCtD
Clemastine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00686	CcSEcCtD
Clemastine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00146	0.00686	CcSEcCtD
Clemastine—Neuritis—Prednisone—chronic obstructive pulmonary disease	0.00146	0.00685	CcSEcCtD
Clemastine—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00673	CcSEcCtD
Clemastine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00141	0.00663	CcSEcCtD
Clemastine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00659	CcSEcCtD
Clemastine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00139	0.00655	CcSEcCtD
Clemastine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00138	0.00647	CcSEcCtD
Clemastine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.00625	CcSEcCtD
Clemastine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00622	CcSEcCtD
Clemastine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00609	CcSEcCtD
Clemastine—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.00605	CcSEcCtD
Clemastine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.00604	CcSEcCtD
Clemastine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00594	CcSEcCtD
Clemastine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00123	0.00581	CcSEcCtD
Clemastine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00123	0.00581	CcSEcCtD
Clemastine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00574	CcSEcCtD
Clemastine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00122	0.00572	CcSEcCtD
Clemastine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00569	CcSEcCtD
Clemastine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00561	CcSEcCtD
Clemastine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00557	CcSEcCtD
Clemastine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00557	CcSEcCtD
Clemastine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00553	CcSEcCtD
Clemastine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00552	CcSEcCtD
Clemastine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00552	CcSEcCtD
Clemastine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.00551	CcSEcCtD
Clemastine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00115	0.00542	CcSEcCtD
Clemastine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00114	0.00536	CcSEcCtD
Clemastine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00532	CcSEcCtD
Clemastine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00532	CcSEcCtD
Clemastine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00529	CcSEcCtD
Clemastine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00526	CcSEcCtD
Clemastine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00522	CcSEcCtD
Clemastine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00522	CcSEcCtD
Clemastine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00521	CcSEcCtD
Clemastine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00521	CcSEcCtD
Clemastine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00519	CcSEcCtD
Clemastine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00516	CcSEcCtD
Clemastine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00511	CcSEcCtD
Clemastine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00506	CcSEcCtD
Clemastine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00502	CcSEcCtD
Clemastine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00502	CcSEcCtD
Clemastine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00502	CcSEcCtD
Clemastine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00493	CcSEcCtD
Clemastine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00492	CcSEcCtD
Clemastine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00491	CcSEcCtD
Clemastine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00482	CcSEcCtD
Clemastine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00482	CcSEcCtD
Clemastine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00474	CcSEcCtD
Clemastine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000986	0.00464	CcSEcCtD
Clemastine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000986	0.00464	CcSEcCtD
Clemastine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000966	0.00454	CcSEcCtD
Clemastine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000962	0.00452	CcSEcCtD
Clemastine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000962	0.00452	CcSEcCtD
Clemastine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000945	0.00445	CcSEcCtD
Clemastine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000934	0.00439	CcSEcCtD
Clemastine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000931	0.00438	CcSEcCtD
Clemastine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000921	0.00433	CcSEcCtD
Clemastine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000921	0.00433	CcSEcCtD
Clemastine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000915	0.0043	CcSEcCtD
Clemastine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000908	0.00427	CcSEcCtD
Clemastine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.0009	0.00423	CcSEcCtD
Clemastine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000892	0.00419	CcSEcCtD
Clemastine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000892	0.00419	CcSEcCtD
Clemastine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000887	0.00417	CcSEcCtD
Clemastine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000886	0.00417	CcSEcCtD
Clemastine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000877	0.0935	CbGpPWpGaD
Clemastine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000876	0.00412	CcSEcCtD
Clemastine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000876	0.00412	CcSEcCtD
Clemastine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000873	0.00411	CcSEcCtD
Clemastine—Azelastine—CYP1A1—chronic obstructive pulmonary disease	0.000871	0.276	CrCbGaD
Clemastine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00087	0.00409	CcSEcCtD
Clemastine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000868	0.00408	CcSEcCtD
Clemastine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000868	0.00408	CcSEcCtD
Clemastine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000867	0.00408	CcSEcCtD
Clemastine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000858	0.00404	CcSEcCtD
Clemastine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000857	0.00403	CcSEcCtD
Clemastine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00085	0.004	CcSEcCtD
Clemastine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00085	0.004	CcSEcCtD
Clemastine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00085	0.004	CcSEcCtD
Clemastine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000843	0.00396	CcSEcCtD
Clemastine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000843	0.00396	CcSEcCtD
Clemastine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000842	0.00396	CcSEcCtD
Clemastine—Azelastine—CYP1A2—chronic obstructive pulmonary disease	0.00084	0.267	CrCbGaD
Clemastine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000836	0.00393	CcSEcCtD
Clemastine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000832	0.00391	CcSEcCtD
Clemastine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000828	0.00389	CcSEcCtD
Clemastine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000824	0.00387	CcSEcCtD
Clemastine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000821	0.00386	CcSEcCtD
Clemastine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000819	0.00385	CcSEcCtD
Clemastine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000812	0.00382	CcSEcCtD
Clemastine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000812	0.00382	CcSEcCtD
Clemastine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000811	0.00382	CcSEcCtD
Clemastine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000809	0.0038	CcSEcCtD
Clemastine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000808	0.0038	CcSEcCtD
Clemastine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000803	0.00377	CcSEcCtD
Clemastine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000796	0.00374	CcSEcCtD
Clemastine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000777	0.00365	CcSEcCtD
Clemastine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000775	0.0827	CbGpPWpGaD
Clemastine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000769	0.00362	CcSEcCtD
Clemastine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000767	0.00361	CcSEcCtD
Clemastine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000765	0.0036	CcSEcCtD
Clemastine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000753	0.00354	CcSEcCtD
Clemastine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000726	0.00341	CcSEcCtD
Clemastine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000707	0.00333	CcSEcCtD
Clemastine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000707	0.00333	CcSEcCtD
Clemastine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000693	0.00326	CcSEcCtD
Clemastine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000675	0.00317	CcSEcCtD
Clemastine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000675	0.00317	CcSEcCtD
Clemastine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000668	0.00314	CcSEcCtD
Clemastine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000665	0.00312	CcSEcCtD
Clemastine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000661	0.00311	CcSEcCtD
Clemastine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000652	0.00307	CcSEcCtD
Clemastine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000652	0.00307	CcSEcCtD
Clemastine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000639	0.003	CcSEcCtD
Clemastine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000637	0.00299	CcSEcCtD
Clemastine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000634	0.0676	CbGpPWpGaD
Clemastine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000627	0.00295	CcSEcCtD
Clemastine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000627	0.00295	CcSEcCtD
Clemastine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000618	0.0029	CcSEcCtD
Clemastine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000618	0.0029	CcSEcCtD
Clemastine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000617	0.0029	CcSEcCtD
Clemastine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000616	0.00289	CcSEcCtD
Clemastine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000614	0.00289	CcSEcCtD
Clemastine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000605	0.00284	CcSEcCtD
Clemastine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000596	0.0028	CcSEcCtD
Clemastine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000592	0.00278	CcSEcCtD
Clemastine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000588	0.00276	CcSEcCtD
Clemastine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000586	0.00275	CcSEcCtD
Clemastine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000586	0.00275	CcSEcCtD
Clemastine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000583	0.00274	CcSEcCtD
Clemastine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000574	0.0027	CcSEcCtD
Clemastine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000567	0.00266	CcSEcCtD
Clemastine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000553	0.0026	CcSEcCtD
Clemastine—Mesoridazine—HTR2A—chronic obstructive pulmonary disease	0.000544	0.173	CrCbGaD
Clemastine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000534	0.00251	CcSEcCtD
Clemastine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000521	0.00245	CcSEcCtD
Clemastine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000516	0.00243	CcSEcCtD
Clemastine—Thioridazine—CYP1A2—chronic obstructive pulmonary disease	0.000487	0.154	CrCbGaD
Clemastine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000483	0.00227	CcSEcCtD
Clemastine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000479	0.00225	CcSEcCtD
Clemastine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000448	0.00211	CcSEcCtD
Clemastine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00044	0.00207	CcSEcCtD
Clemastine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000437	0.00205	CcSEcCtD
Clemastine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000427	0.00201	CcSEcCtD
Clemastine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000412	0.00194	CcSEcCtD
Clemastine—Thioridazine—HTR2A—chronic obstructive pulmonary disease	0.000411	0.13	CrCbGaD
Clemastine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000388	0.00182	CcSEcCtD
Clemastine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000379	0.00178	CcSEcCtD
Clemastine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000375	0.00176	CcSEcCtD
Clemastine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00037	0.00174	CcSEcCtD
Clemastine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000353	0.00166	CcSEcCtD
Clemastine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000351	0.00165	CcSEcCtD
Clemastine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000348	0.00164	CcSEcCtD
Clemastine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000342	0.00161	CcSEcCtD
Clemastine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000337	0.00159	CcSEcCtD
Clemastine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000334	0.00157	CcSEcCtD
Clemastine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.00157	CcSEcCtD
Clemastine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000332	0.00156	CcSEcCtD
Clemastine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000322	0.0343	CbGpPWpGaD
Clemastine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00032	0.0015	CcSEcCtD
Clemastine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000317	0.00149	CcSEcCtD
Clemastine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000278	0.00131	CcSEcCtD
Clemastine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00125	CcSEcCtD
Clemastine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00121	CcSEcCtD
Clemastine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000254	0.0271	CbGpPWpGaD
Clemastine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000247	0.00116	CcSEcCtD
Clemastine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000247	0.0263	CbGpPWpGaD
Clemastine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00114	CcSEcCtD
Clemastine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00023	0.00108	CcSEcCtD
Clemastine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000213	0.0227	CbGpPWpGaD
Clemastine—HRH1—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000208	0.0222	CbGpPWpGaD
Clemastine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000204	0.0218	CbGpPWpGaD
Clemastine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000191	0.0204	CbGpPWpGaD
Clemastine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000185	0.0197	CbGpPWpGaD
Clemastine—HRH1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000175	0.0186	CbGpPWpGaD
Clemastine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.0177	CbGpPWpGaD
Clemastine—HRH1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000163	0.0173	CbGpPWpGaD
Clemastine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.0168	CbGpPWpGaD
Clemastine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000154	0.0165	CbGpPWpGaD
Clemastine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000151	0.0161	CbGpPWpGaD
Clemastine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000149	0.0158	CbGpPWpGaD
Clemastine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.0154	CbGpPWpGaD
Clemastine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.0148	CbGpPWpGaD
Clemastine—HRH1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000137	0.0146	CbGpPWpGaD
Clemastine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000134	0.0143	CbGpPWpGaD
Clemastine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000122	0.0131	CbGpPWpGaD
Clemastine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.0129	CbGpPWpGaD
Clemastine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000116	0.0124	CbGpPWpGaD
Clemastine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.0122	CbGpPWpGaD
Clemastine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.0117	CbGpPWpGaD
Clemastine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.0108	CbGpPWpGaD
Clemastine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	9.71e-05	0.0104	CbGpPWpGaD
Clemastine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	9.09e-05	0.0097	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.03e-05	0.00963	CbGpPWpGaD
Clemastine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.82e-05	0.00941	CbGpPWpGaD
Clemastine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.71e-05	0.00929	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.15e-05	0.00763	CbGpPWpGaD
Clemastine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	7.14e-05	0.00761	CbGpPWpGaD
Clemastine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.41e-05	0.00684	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	6.4e-05	0.00682	CbGpPWpGaD
Clemastine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.33e-05	0.00675	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	5.9e-05	0.0063	CbGpPWpGaD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	5.77e-05	0.00616	CbGpPWpGaD
Clemastine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	5.69e-05	0.00607	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	5.48e-05	0.00585	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.2e-05	0.00555	CbGpPWpGaD
Clemastine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	5.19e-05	0.00553	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	4.68e-05	0.00499	CbGpPWpGaD
Clemastine—HRH1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	4.64e-05	0.00495	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.57e-05	0.00488	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.52e-05	0.00482	CbGpPWpGaD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.19e-05	0.00447	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	4.17e-05	0.00445	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	4.15e-05	0.00443	CbGpPWpGaD
Clemastine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.14e-05	0.00441	CbGpPWpGaD
Clemastine—HRH1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	4.06e-05	0.00433	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	4.01e-05	0.00428	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.8e-05	0.00405	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.75e-05	0.004	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	3.63e-05	0.00387	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	3.44e-05	0.00367	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	3.42e-05	0.00365	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.4e-05	0.00363	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.17e-05	0.00338	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.14e-05	0.00335	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.13e-05	0.00333	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.07e-05	0.00328	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.99e-05	0.00319	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.96e-05	0.00315	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.93e-05	0.00312	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.91e-05	0.00311	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.87e-05	0.00306	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.76e-05	0.00295	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.72e-05	0.00291	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.69e-05	0.00287	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.66e-05	0.00283	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.62e-05	0.00279	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.48e-05	0.00265	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.45e-05	0.00261	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.36e-05	0.00252	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.34e-05	0.0025	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.22e-05	0.00237	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.14e-05	0.00228	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.07e-05	0.00221	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.07e-05	0.00221	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.05e-05	0.00218	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.04e-05	0.00218	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.9e-05	0.00203	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.88e-05	0.002	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.81e-05	0.00193	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.78e-05	0.0019	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.66e-05	0.00177	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.64e-05	0.00175	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.57e-05	0.00167	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.48e-05	0.00158	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.47e-05	0.00157	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.45e-05	0.00155	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.43e-05	0.00153	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.34e-05	0.00143	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.33e-05	0.00142	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.32e-05	0.00141	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.27e-05	0.00135	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.26e-05	0.00135	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.26e-05	0.00134	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.2e-05	0.00128	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.16e-05	0.00123	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.05e-05	0.00112	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.62e-06	0.00103	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	9.36e-06	0.000998	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.25e-06	0.000987	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.7e-06	0.000928	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.6e-06	0.000917	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.94e-06	0.000847	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.82e-06	0.000834	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.73e-06	0.000825	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.15e-06	0.000762	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.09e-06	0.000757	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.05e-06	0.000752	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.5e-06	0.000693	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.49e-06	0.000692	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.45e-06	0.000688	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.2e-06	0.000662	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.77e-06	0.000615	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.42e-06	0.000578	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.35e-06	0.00057	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.11e-06	0.000545	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.05e-06	0.000539	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.98e-06	0.000531	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.74e-06	0.000506	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.72e-06	0.000504	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.61e-06	0.000492	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.53e-06	0.000483	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.32e-06	0.000461	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.25e-06	0.000453	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.83e-06	0.000409	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.64e-06	0.000389	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.54e-06	0.000378	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.5e-06	0.000373	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.47e-06	0.00037	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.26e-06	0.000347	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.21e-06	0.000342	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.11e-06	0.000332	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.09e-06	0.000329	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.07e-06	0.000328	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.86e-06	0.000305	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.8e-06	0.000299	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.35e-06	0.000251	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.15e-06	0.00023	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.1e-06	0.000224	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.01e-06	0.000214	CbGpPWpGaD
